ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1535

Depression in Rheumatoid Arthritis

Christian Ferro1, Carlos Ríos2, Mario Moreno Alvarez3, Maria Jose Intriago4, Génessis Maldonado4, Claudia Aguirre4, Carlos Paredes4, Jenny Cardenas4, Nelson Cordova5, Rafael López5 and Jose Martinez5, 1Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador, 2Centro de Reumatología y Rehabilitación CERER, Guayaquil, Ecuador, 3Rheumatology, Hospital Luis Vernaza, Rheumatology Service, Guayaquil, Ecuador, 4Universidad Espíritu Santo, Guayaquil, Ecuador, 5Hospital Luis Vernaza, Guayaquil, Ecuador

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Depression and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression is an important comorbidity in patients with rheumatoid arthritis (RA). Its incidence is variable (10-25%), being more frequent in women1. Wolfe et al. determined that pain, HAQ-DI and disease activity predict depression2. The main objective is to determine depression in patients with RA by the PHQ-9 questionnaire and evaluate its relationship with disease activity.

Methods: A cross-sectional study was conducted in patients with established diagnosis of RA according to the criteria of the ACR-1988, from the Luis Vernaza Hospital and a private rheumatology center. The database included demographic data, pain visual analog scale (VAS), activity index DAS-28, HAQ-DI disability index and the PHQ-9 questionnaire. Data was loaded and analyzed in the statistical program SPSS V. 22. Statistical significance used was 0.01, with a 99% reliability.

Results: 184 patients with a mean age of 51 years (20-90) were included, 90.8% women and 9.2% men. The mean age of onset of the disease was 40 years (18-49) with a delay of visit to the specialist of 26 months (1-432). 94.6% were mestizos, 3.8%, whites and 1.6% afroecuadorians, 50% were married, 16.3%, cohabiting 16.3% divorced, 9.2% single, and 8.2% widowed. The mean patient VAS was 3.4 (0-10) and physician VAS 2.8 (0-10). The mean DAS28-CRP was 3.11 (0.7-7.6), with 44% (81) in remission, 16.8% (31) low activity, 32.1% (59) moderate activity and 7.1% (13) high activity. 21.7% (40) patients had HAQ-DI disability and 1.6% (3) severe disability. The mean PHQ-9 was 5.39 points (0-24). According to this questionnaire, depression was found in 42.9% (79), 24.5% (45) mild depression, 9.8% (18) moderate, 7.1% (13) moderate-severe and 1.6% (3) severe. Of these, 89.9% (71) were women and 10.1% (8) men. Depression related to disease activity with DAS-28. 66.7% (20) of patients in remission had mild depression while 70% (7) patients with high activity had moderate to severe depression (p = 0.009). Mean DAS-28 for patients with moderate to severe depression was higher than those with mild depression (4.0 vs. 2.9, p = 0.004) Disability also related to depression levels as 40.7% (11) patients with functional disability had moderate to severe depression, compared with 35.1% (13) patients without disability (p = 0.009). Likewise, the average HAQ of patients with major depression was higher (p = 0.000). The average patient VAS in people with mild depression was 3.7, while in moderate to severe depression was 5.4 (p = 0.000). In the physician VAS, it was 3.1 for mild depression, and 4.6 for moderate to severe depression (p = 0.000). The number of tender and swollen joints was higher in patients with major depression than in those with mild depression (p = 0.000).

Conclusion: The presence of depression was common in our population, women were the most affected. Depression was related with disability and disease activity. The presence of depression in ecuadorian patients with RA was similar to that of other populations. This is the first study of depression in patients with RA in Ecuador.

  1. Rathbun, A., Harrold, R. & Reed, G. Clin Exp Rheumatol. 2014. Jul
  2. Wolfe, F. & Hawley,DJ. T. The Journal of Rheumatology 1993, 20(12): 2032-2037

Disclosure: C. Ferro, None; C. Ríos, None; M. Moreno Alvarez, None; M. J. Intriago, None; G. Maldonado, None; C. Aguirre, None; C. Paredes, None; J. Cardenas, None; N. Cordova, None; R. López, None; J. Martinez, None.

To cite this abstract in AMA style:

Ferro C, Ríos C, Moreno Alvarez M, Intriago MJ, Maldonado G, Aguirre C, Paredes C, Cardenas J, Cordova N, López R, Martinez J. Depression in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/depression-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology